Cardiovascular Pathology
Volume 19, Issue 3 , Pages 147-152, May 2010

Large animal models for diastolic dysfunction and diastolic heart failure—a review of the literature

  • Shay Dubi

      Affiliations

    • Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
  • ,
  • Yaron Arbel

      Affiliations

    • Department of Internal Medicine ‘D’, Tel Aviv Sourasky Medical Center, affiliated with the Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
    • Corresponding Author InformationCorresponding author. Tel Aviv Sourasky Medical Center, Weizman 6, Tel Aviv 69513, Israel. Tel.: +972 524 266151; fax: +972 3 6973259.

Received 13 February 2008; received in revised form 11 August 2008; accepted 16 December 2008. published online 12 February 2009.

Abstract 

Diastolic heart failure (DHF) or heart failure with preserved systolic left ventricular function is estimated to account for approximately 40% of heart failure cases. Medical treatment of patients with DHF is limited and mainly empirical. Device-based therapy has an increasing role in the treatment of systolic heart failure and may have a future role in the treatment of DHF patients. Diastolic dysfunction and DHF are associated with anatomical and physiological characteristics, which need to be modeled in large animals in order to allow evaluation of device-based therapies, prior to clinical studies. In this article, we will review the large animal models for diastolic dysfunction and heart failure.

Keywords: DHF, Diastolic heart failure, Diastolic dysfunction, Animal model, Heart failure

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Disclosure: Shay Dubi is a shareholder in CorAssist Cardiovascular Limited.

PII: S1054-8807(08)00189-0

doi:10.1016/j.carpath.2008.12.008

Cardiovascular Pathology
Volume 19, Issue 3 , Pages 147-152, May 2010